Sleep Number Announces First Quarter 2026 Results

Sleep Number Announces First Quarter 2026 Results May 12, 2026 Reports First Quarter 2026 Net Sales of $319 million Advances Turnaround Through Product and Brand Reset to Drive Sustainable Growth Continues Focus on Long-term Capital Structure Solutions, Including Strategic and Financing Options Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended April 4, 2026. Linda Findley, President and CEO, commented, “Q1 came in as expected given the soft start to the year, but year-over-year demand improved steadily throughout the quarter, ending with growth in March over last year. We are confident in the early positive metrics we are seeing from our new product launch and marketing campaigns, and the customer feedback on our new beds is fantastic. We believe this, combined with the full realization of our cost savings actions, puts us in line with the financial indications we highlighted in the previous earnings call. “With the additional short-term liquidity provided by our existing lender group, we are fully focused on securing a long-term capital solution and are moving through the process of evaluating a range of strategic and financing options to maximize stakeholder value. I’m proud of the significant progress the team has made on the turnaround, and I believe we have positioned Sleep Number well for future growth.” First Quarter Overview (all comparisons year-over-year unless otherwise noted) Net sales of $319 million were down 18.9%, driven by lower volume and a reduced store count.Gross profit was $185 million, a decrease of $56 million. Gross profit margin of 57.9% compared to 61.2% for the same period last year, primarily driven by a shift in mix to the new ComfortMode bed and discounting of legacy inventory.Operating expenses were $221 million. Adjusted operating expenses before restructuring and other non-recurring costs were $195 million, a decrease of $42 million, or 18%, driven by lower marketing and selling expenses, general and administrative expenses, and research and development expenses.Restructuring and other non-recurring costs in the quarter were $22 million, primarily driven by store and office closure costs, strategic alternative legal and advisory fees, other professional and bank fees and severance related expenses.Net loss was $50 million, compared to a net loss of $9 million for the same period last year, driven primarily by lower net sales, partially offset by lower operating expenses.Adjusted EBITDA was $6 million, down 74%, driven by a decline in net sales and associated loss of fixed cost leverage, partially offset by lower operating expenses. Adjusted EBITDA margin of 1.8%, down 380 basis points ("bps"). Cash Flows, Liquidity and Balance Sheet Highlights (all comparisons year-over-year unless otherwise noted) Net cash used in year-to-date operating activities was $8 million, down $5 million.Year-to-date Free cash flow was a use of $13.2 million. Additional Business Highlights Sleep Number is executing a turnaround strategy centered on product, marketing and distribution with ongoing cost savings and operating efficiencies to reignite growth and increase financial resilience. Recent highlights include: Product Portfolio Transformation – Completed the largest product redesign in nearly a decade, and all stores are fully reset. Early customer response has been encouraging, with initial indicators showing improved product engagement, strong attachment to the ComfortNext portfolio, and a simplified shopping experience across stores and digital channels.Modernized Marketing Foundation – Launched “To a Good Life’s Sleep™,” the company’s first major integrated campaign in several years and the next phase of its brand evolution. The campaign supports the redesigned portfolio with benefit-led messaging focused on personalized, adjustable comfort that adapts as customers’ needs change.Cost Structure Reset – Continued to right-size the fixed cost base, with approximately $200 million of annualized cost savings already executed, including efficiencies across G&A, corporate structure, technology, and real estate.Capital Structure Review – Reached an agreement with existing lenders that provides relief from certain financial covenants and adds $55 million of incremental liquidity, including a new $25 million term loan as detailed in the company's prior press release and Form 8-K filed on April 28, 2026. The agreement provides additional stability and flexibility to continue executing the turnaround while the company works with advisors to evaluate strategic and financing options for a longer-term capital structure solution. Financial Outlook In connection with the company's previously announced engagement of Guggenheim Securities to evaluate strategic and financing options, the company is not providing financial guidance. The company, however, expects performance to be consistent with the financial indications it provided on the 2025 fourth quarter and full year earnings call. The company does not intend to provide forward-looking financial guidance while the strategic process is ongoing. Conference Call Information Management will host its regularly scheduled conference call to discuss the company’s results at 8:30 a.m. ET (7:30 a.m. CT; 5:30 a.m. PT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number® is the leader in personalized sleep wellness. Its mattresses are designed to evolve with each sleeper to help them feel and perform their best. With adjustable firmness, pressure-relieving support and temperature balancing comfort built into every mattress, Sleep Number beds adapt to customers’ changing needs, night after night, year after year. Backed by almost 40 years of innovation, 1,000+ patents and patents pending, and billions of hours of sleep data, Sleep Number has helped more than 16 million people achieve their best sleep. The fully integrated model ensures quality, durability, and care at every step—from design and craftsmanship to delivery and long-term support. Sleep Number products are awarded the industry's top recognitions, including ranked #1 in customer satisfaction for mattresses purchased in-store and online, and #1 in comfort, by J.D. Power. In addition, the company is the Official Sleep + Wellness Partner of the NFL, marking a relationship that leverages players, team partnerships, and league-wide initiatives to amplify brand awareness and drive consumer engagement. Sleep Number mattresses, bases, bedding, and furniture are available exclusively at its over 570 stores nationwide and online. To learn more, visit SleepNumber.com or a store near you. Forward-looking Statements Statements used in this news release relating to future plans, events, financial results or performance, such as the statements about the company’s ability to: advance and execute its turnaround to drive growth and increase financial resilience; achieve and fully realize cost savings and operational efficiencies; perform in line with its financial indications highlighted in the previous earnings call; successfully evaluate and execute strategic and financing options to achieve a long-term capital structure solution to maximize value; and realize the expected benefits from its new product portfolio and marketing initiatives are forward-looking statements subject to certain risks and uncertainties which could cause the company’s results to differ materially, including its ability to continue as a going concern as detailed in the company's Annual Report on Form 10-K for fiscal year 2025 and its Quarterly Report on Form 10-Q for the first quarter of fiscal 2026 and secure a long-term capital solution through an evaluation of strategic and financing options. The most important risks and uncertainties are described in the company’s filings with the Securities and Exchange Commission, including in Item 1A of the company’s Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement. SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (unaudited – in thousands, except per share amounts) Three Months Ended April 4, 2026 % of Net Sales March 29, 2025 % of Net Sales Net sales $ 318,987 100.0 % $ 393,261 100.0 % Cost of sales 134,372 42.1 % 152,726 38.8 % Gross profit 184,615 57.9 % 240,535 61.2 % Operating expenses: Sales and marketing 160,795 50.4 % 189,103 48.1 % General and administrative 33,592 10.5 % 38,619 9.8 % Research and development 5,348 1.7 % 10,903 2.8 % Restructuring costs 21,736 6.8 % 60 0.0 % Total operating expenses 221,471 69.4 % 238,685 60.7 % Operating (loss) income (36,856 ) (11.6 %) 1,850 0.5 % Interest expense, net 13,103 4.1 % 11,081 2.8 % Loss before income taxes (49,959 ) (15.7 %) (9,231 ) (2.3 %) Income tax expense (benefit) 338 0.1 % (585 ) (0.1 %) Net loss $ (50,297 ) (15.8 %) $ (8,646 ) (2.2 %) Net loss per share – basic and diluted $ (2.19 ) $ (0.38 ) Reconciliation of weighted-average shares outstanding: Basic weighted-average shares outstanding 22,991 22,706 Dilutive effect of stock-based awards — — Diluted weighted-average shares outstanding 22,991 22,706 For the three months ended April 4, 2026 and March 29, 2025, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share. SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (unaudited – in thousands, except per share amounts) subject to reclassification April 4, 2026 January 3, 2026 Assets Current assets: Cash and cash equivalents $ 1,484 $ 1,693 Accounts receivable, net of allowances of $656 and $694, respectively 13,354 15,502 Inventories 78,216 82,233 Prepaid expenses 19,727 13,656 Other current assets 30,694 36,873 Total current assets 143,475 149,957 Non-current assets: Property and equipment, net 73,755 86,528 Operating lease right-of-use assets 295,315 311,723 Goodwill and intangible assets, net 66,131 66,186 Deferred income taxes 399 399 Other non-current assets 61,933 65,267 Total assets $ 641,008 $ 680,060 Liabilities and Shareholders’ Deficit Current liabilities: Borrowings under credit facility $ 605,600 $ 588,200 Accounts payable 116,395 117,977 Customer prepayments 43,338 39,527 Accrued sales returns 12,266 12,817 Compensation and benefits 19,415 14,975 Taxes and withholding 10,908 11,429 Operating lease liabilities 79,340 81,191 Other current liabilities 44,447 46,430 Total current liabilities 931,709 912,546 Non-current liabilities: Operating lease liabilities 268,697 273,111 Other non-current liabilities 66,921 72,878 Total liabilities 1,267,327 1,258,535 Shareholders’ deficit: Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding — — Common stock, $0.01 par value; 142,500 shares authorized, 23,049 and 22,860 shares issued and outstanding, respectively 230 229 Additional paid-in capital 34,906 32,454 Accumulated deficit (661,455 ) (611,158 ) Total shareholders’ deficit (626,319 ) (578,475 ) Total liabilities and shareholders’ deficit $ 641,008 $ 680,060 SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Statements of Cash Flows (unaudited – in thousands) subject to reclassification Three Months Ended April 4, 2026 March 29, 2025 Cash flows from operating activities: Net loss $ (50,297 ) $ (8,646 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 12,371 14,836 Stock-based compensation 2,826 3,951 Inventory obsolescence write off 2,099 — Loss on disposal and impairment of leased assets 17,539 17 Deferred income taxes — (1,321 ) Changes in operating assets and liabilities: Accounts receivable 2,148 3,291 Inventories 1,918 (724 ) Income taxes 482 736 Prepaid expenses and other assets (4,266 ) 781 Accounts payable 3,818 8,784 Customer prepayments 3,811 (6,576 ) Accrued compensation and benefits 4,354 (9,686 ) Other taxes and withholding (1,003 ) (1,925 ) Other accruals and liabilities (3,551 ) (6,144 ) Net cash used in operating activities (7,751 ) (2,626 ) Cash flows from investing activities: Purchases of property and equipment (5,441 ) (4,599 ) Net cash used in investing activities (5,441 ) (4,599 ) Cash flows from financing activities: Net increase in short-term borrowings 13,805 9,087 Repurchases of common stock (373 ) (563 ) Debt issuance costs (449 ) (1,558 ) Net cash provided by financing activities 12,983 6,966 Net decrease in cash and cash equivalents (209 ) (259 ) Cash and cash equivalents, at beginning of period 1,693 1,950 Cash and cash equivalents, at end of period $ 1,484 $ 1,691 SLEEP NUMBER CORPORATION AND SUBSIDIARIES Supplemental Financial Information (unaudited) Three Months Ended April 4, 2026 March 29, 2025 Percent of sales: Retail stores 87.0 % 87.6 % Online, phone, chat and other 13.0 % 12.4 % Total Company 100.0 % 100.0 % Sales change rates: Retail comparable-store sales (17 %) (15 %) Online, phone and chat (15 %) (12 %) Total Retail comparable sales change (16 %) (15 %) Net opened/closed stores and other (3 %) (1 %) Total Company (19 %) (16 %) Stores open: Beginning of period 600 640 Opened — 2 Closed (23 ) (5 ) End of period 577 637 Other metrics: Average sales per store ($ in 000's)1 $ 2,170 $ 2,495 Average sales per square foot1 $ 700 $ 807 Stores > $2 million net sales2 31 % 51 % Stores > $3 million net sales2 6 % 15 % Average revenue per mattress unit3 $ 6,021 $ 5,992 1 Trailing twelve months Total Retail comparable sales per store open at least one year. 2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales). 3 Represents Total Retail net sales divided by Total Retail mattress units. SLEEP NUMBER CORPORATION AND SUBSIDIARIES Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) (in thousands) We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net loss plus: income tax expense (benefit), interest expense, depreciation and amortization, stock-based compensation, restructuring costs, other non-recurring items, and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure: Three Months Ended Trailing Twelve Months Ended April 4, 2026 March 29, 2025 April 4, 2026 March 29, 2025 Net loss $ (50,297 ) $ (8,646 ) $ (173,609 ) $ (21,498 ) Income tax expense (benefit) 338 (585 ) 36,907 (6,472 ) Interest expense 13,103 11,081 51,404 47,150 Depreciation and amortization 11,126 14,406 49,889 62,240 Stock-based compensation 2,827 3,951 5,158 11,278 Restructuring costs1 21,736 60 72,373 7,526 Other non-recurring items2 6,917 1,774 19,841 2,772 Asset impairments — — — 1,220 Adjusted EBITDA $ 5,750 $ 22,041 $ 61,963 $ 104,216 1 Represents costs related to business restructuring actions. 2 Non‑recurring costs represent discrete, non‑operational items, including obsolete inventory associated with the Company’s product transition, strategic alternative legal and advisory fees, executive transition and search fees, proxy contest costs, public debt issuance cost write-off, tax matters and other non‑routine professional and bank fees. These amounts are treated as permitted add-backs in the calculation of Adjusted EBITDA in accordance with the Company’s Credit Agreement. Free Cash Flow (in thousands) Three Months Ended Trailing Twelve Months Ended April 4, 2026 March 29, 2025 April 4, 2026 March 29, 2025 Net cash used in operating activities $ (7,751 ) $ (2,626 ) $ (8,408 ) $ (9,228 ) Subtract: Purchases of property and equipment 5,441 4,599 15,249 18,796 Free cash flow $ (13,192 ) $ (7,225 ) $ (23,657 ) $ (28,024 ) Reconciliation of GAAP to Non-GAAP Financial Measures (in thousands) Three Months Ended April 4, 2026 March 29, 2025 Operating expenses $ 221,471 $ 238,685 Subtract: Restructuring costs 21,736 60 Subtract: Other non-recurring items1 4,818 1,774 Non-GAAP operating expenses $ 194,917 $ 236,851 Adjusted operating expense reduction versus prior period, excluding restructuring costs and non-recurring items $ 41,934 1 Excludes inventory obsolescence write off of $2.1 million recorded in the three months ended April 4, 2026, which is included in the cost of sales line on the consolidated statement of operations. Note - Our Adjusted EBITDA, Free Cash Flow and Adjusted Operating Expenses are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. GAAP - generally accepted accounting principles in the U.S. SLEEP NUMBER CORPORATION AND SUBSIDIARIES Calculation of Return on Invested Capital (Adjusted ROIC) (in thousands) Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures: Trailing Twelve Months Ended April 4, 2026 March 29, 2025 Adjusted net operating profit after taxes (Adjusted NOPAT) Operating (loss) income $ (85,299 ) $ 19,180 Add: Operating lease interest1 23,832 26,098 Less: Income taxes2 7,902 (10,022 ) Adjusted NOPAT $ (53,565 ) $ 35,256 Average adjusted invested capital Total deficit $ (626,317 ) $ (456,844 ) Add: Long-term debt3 605,720 557,921 Add: Operating lease liabilities4 348,037 376,909 Total adjusted invested capital at end of period $ 327,440 $ 477,986 Average adjusted invested capital5 $ 408,437 $ 487,361 Adjusted ROIC6 (13.1 %) 7.2 % 1 Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases. 2 Reflects annual effective income tax rates, before discrete adjustments, of 12.9% and 22.1% for April 4, 2026 and March 29, 2025, respectively. 3 Long-term debt includes existing finance lease liabilities. 4 Reflects operating lease liabilities included in our financial statements under ASC 842. 5 Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances. 6 Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital. Note - The Company's Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. GAAP - generally accepted accounting principles in the U.S. Source: Sleep Number Corporation